NCT04439175
Clinical Trial Information
Trial Number: NCT04439175 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Lymphoma - Miscellaneous
- Miscellaneous Neoplasm - Solid Tumor
Trial Title:
MATCH Treatment Subprotocol I: GDC-0032 (taselisib) in Patients with Tumors (other than breast cancer) with PIK3CA mutation but without KRAS mutation or PTEN loss
Study ID:
EAY131-I
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®